As a professionalPOCT solution provider,Microprofit Biotech participated in theconference this year at booth 3F28 with our main brand fluorecare®.We exhibited our in-vitro diagnostic products based onFIA Quantitative POCT Platform drawing many visitors’ attention. Our sales managers had a detailed communication with every possible customers and the products received great comments. We also had appointments with many cooperated clients in advance and met them in this convention. It was our great pleasure to meet theseacquainted customers in Düsseldorf; meanwhile, they were delighted with our continuously increasing test items and gave us valuable suggestions.

The major test items of fluorecare® immunofluorescence quantitative platform cover tumor, hormone, myocardium, infection and diabetes markers. They can be testedrapidly and accurately within simple steps.The matching fluorecare® immunofluorescence quantitative analyzer is lightweight and convenient, suitable for a variety of medical scenarios, especially the primary medical institutions and emergency departments. Based on the 40+ test items we have now, our company continues to optimize existing products and launch new testing projects, providing quality products and services for customers all over the world.

The 4 days in MEDICA 2019 are busy but meaningful. It is our honor to meet all the customers and visitors. We are looking forward to meet you at MEDICA 2020. In addition, Microprofit is going to participate in Medlab Middle east 2020 in Dubai fromFebruary 3rd to 6th. We hope to meet you at our booth Z1.A49.